TMED5 and cancer: As would be expected, elevated expression of TMED5 significantly abrogated miR-183-5p overexpression-mediated anti-proliferation (Fig. 6C, D) and pro-apoptosis (Fig. 6E, F) effects in the two cancer cell lines.